The COX-2-1195AA Genotype Is Associated with Diffuse-Type Gastric Cancer in Korea

被引:21
|
作者
Shin, Woon Geon [1 ]
Kim, Ha Jung [2 ]
Cho, Sung Jin [3 ]
Kim, Hyoung Su [1 ]
Kim, Kyung Ho [1 ]
Jang, Myoung Kuk [1 ]
Lee, Jin Heon [1 ]
Kim, Hak Yang [1 ]
机构
[1] Hallym Univ, Coll Med, Dept Internal Med, Seoul 134701, South Korea
[2] Hallym Univ, Coll Med, Lab Study Gastroenterol & Hepatol, Seoul 134701, South Korea
[3] Hallym Univ, Coll Med, Dept Pathol, Seoul 134701, South Korea
关键词
Stomach neoplasms; Diffuse type; COX-2; Polymorphism; HELICOBACTER-PYLORI INFECTION; E-CADHERIN GENE; ATROPHIC GASTRITIS; CYCLOOXYGENASE-2; EXPRESSION; INTESTINAL METAPLASIA; GERMLINE MUTATIONS; INCREASED RISK; POLYMORPHISMS; CARCINOGENESIS; INTERLEUKIN-1;
D O I
10.5009/gnl.2012.6.3.321
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The potential role of the cyclooxygenase (COX)-2 polymorphism has been reported in relation to the risk of gastrointestinal tract malignancies. Therefore, we investigated whether COX-2 polymorphisms are associated with the risk of gastric cancer (GC) in Korea, one of the areas with a high prevalence of this condition. Methods: We evaluated the genotypic frequencies of COX-2-765 and -1195 in 100 peptic ulcer patients, 100 GC patients, and 100 healthy controls. The polymorphisms of the COX-2-765 and -1195 genes were analyzed by polymerase chain reaction and restriction fragment length polymorphisms. Results: The frequencies of the COX-2-1195 GG, GA, and AA genotype were 20%, 60%, and 20% in intestinal-type GC and 8%, 48%, and 44% in diffuse-type GC, respectively (p=0.021). There were no significant differences in the frequency of COX-2-765 genotypes between intestinal-type GC and diffuse-type GC (p=0.603). Age- and sex-adjusted logistic regression analysis showed that the COX-2-1195 AA genotype was the independent risk factor of diffuse-type GC compared with the COX-2-1195 GG genotype (p=0.041; odds ratio, 6.22; 95% confidence interval, 1.077 to 35.870). Conclusions: The COX-2-1195 M genotype may render subjects more susceptible to diffuse-type GC. (Gut Liver 2012;6:321-327)
引用
收藏
页码:321 / 327
页数:7
相关论文
共 50 条
  • [31] Endoscopic mucosal resection (EMR) for diffuse-type mucosal gastric cancer
    Inoue, M
    Gotoda, T
    Soetikno, RM
    Hamanaka, H
    Oda, I
    Saito, D
    GASTROINTESTINAL ENDOSCOPY, 2004, 59 (05) : AB170 - AB170
  • [32] Genomic characterization of life-cycle in diffuse-type gastric cancer
    Ishikawa, Shumpei
    CANCER SCIENCE, 2022, 113 : 1253 - 1253
  • [33] Subtotal versus total gastrectomy for distal diffuse-type gastric cancer
    Gajardo, Jorge A.
    Arriagada, Francisco J.
    Munoz, Florencia D.
    Veloso, Francisca A.
    Pacheco, Francisco A.
    Molina, Hector E.
    Schaub, Thomas P.
    Torres, Osvaldo A.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2024, 38 (12): : 7588 - 7595
  • [34] Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinoma
    Yashiro, Masakazu
    Nishioka, Nobuaki
    Hirakawa, Kosei
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (14) : 2397 - 2403
  • [35] Gene expression signatures for identifying diffuse-type gastric cancer associated with epithelial-mesenchymal transition
    Tanabe, Shihori
    Aoyagi, Kazuhiko
    Yokozaki, Hiroshi
    Sasaki, Hiroki
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (06) : 1955 - 1970
  • [36] Abrogation of RhoA expression and activity is associated with its aberrant splicing in diffuse-type gastric cancer cells
    Miyamoto, Shingo
    Nakabo, Ayaka
    Fukami, Kiyoko
    Yanagihara, Kazuyoshi
    Sakai, Ryuichi
    Yamaguchi, Hideki
    CANCER SCIENCE, 2018, 109 : 894 - 894
  • [37] Nodular gastritis with Helicobacter pylori infection is strongly associated with diffuse-type gastric cancer in young patients
    Kamad, Tomoari
    Tanaka, Aki
    Yamanaka, Yoshiyuki
    Manabe, Noriaki
    Kusunoki, Hiroaki
    Miyamoto, Masaki
    Tanaka, Shinji
    Hata, Jiro
    Chayama, Kazuaki
    Haruma, Ken
    DIGESTIVE ENDOSCOPY, 2007, 19 (04) : 180 - 184
  • [38] A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors
    Hiroshi Fukamachi
    Seon-Kyu Kim
    Jiwon Koh
    Hye Seung Lee
    Yasushi Sasaki
    Kentaro Yamashita
    Taketo Nishikawaji
    Shu Shimada
    Yoshimitsu Akiyama
    Sun-ju Byeon
    Dong-Hyuck Bae
    Keisuke Okuno
    Masatoshi Nakagawa
    Toshiro Tanioka
    Mikito Inokuchi
    Hiroshi Kawachi
    Kiichiro Tsuchiya
    Kazuyuki Kojima
    Takashi Tokino
    Yoshinobu Eishi
    Yong Sung Kim
    Woo Ho Kim
    Yasuhito Yuasa
    Shinji Tanaka
    Journal of Experimental & Clinical Cancer Research, 38
  • [39] The master regulators of causal networks in intestinal- and diffuse-type gastric cancer
    Tanabe, Shihori
    Quader, Sabina
    Ono, Ryuichi
    Cabral, Horacio
    Aoyagi, Kazuhiko
    Hirose, Akihiko
    Yokozaki, Hiroshi
    Sasaki, Hiroki
    CANCER SCIENCE, 2024, 115 : 1777 - 1777
  • [40] Genomic features of Helicobacter pylori-naive diffuse-type gastric cancer
    Namikawa, Ken
    Tanaka, Norio
    Ota, Yuki
    Takamatsu, Manabu
    Kosugi, Mayuko
    Tokai, Yoshitaka
    Yoshimizu, Shoichi
    Horiuchi, Yusuke
    Ishiyama, Akiyoshi
    Yoshio, Toshiyuki
    Hirasawa, Toshiaki
    Amino, Sayuri
    Furuya, Rie
    Gotoh, Osamu
    Kaneyasu, Tomoko
    Nakayama, Izuma
    Imamura, Yu
    Noda, Tetsuo
    Fujisaki, Junko
    Mori, Seiichi
    JOURNAL OF PATHOLOGY, 2022, 258 (03): : 300 - 311